ES2896734T3 - Proteínas novedosas derivadas de la alfa-1-microglobulina y su uso - Google Patents

Proteínas novedosas derivadas de la alfa-1-microglobulina y su uso Download PDF

Info

Publication number
ES2896734T3
ES2896734T3 ES17711205T ES17711205T ES2896734T3 ES 2896734 T3 ES2896734 T3 ES 2896734T3 ES 17711205 T ES17711205 T ES 17711205T ES 17711205 T ES17711205 T ES 17711205T ES 2896734 T3 ES2896734 T3 ES 2896734T3
Authority
ES
Spain
Prior art keywords
seq
absent
asp
lys
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17711205T
Other languages
English (en)
Spanish (es)
Inventor
Lena Wester Rosenlöf
Anneli Edström Hägerwall
Bo Åkerström
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guard Therapeutics International AB
Original Assignee
Guard Therapeutics International AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guard Therapeutics International AB filed Critical Guard Therapeutics International AB
Application granted granted Critical
Publication of ES2896734T3 publication Critical patent/ES2896734T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717Plasma globulins, lactoglobulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
ES17711205T 2016-03-18 2017-03-17 Proteínas novedosas derivadas de la alfa-1-microglobulina y su uso Active ES2896734T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201670158 2016-03-18
PCT/EP2017/056436 WO2017158181A1 (en) 2016-03-18 2017-03-17 Novel alpha-1-microglobulin derived proteins and their use

Publications (1)

Publication Number Publication Date
ES2896734T3 true ES2896734T3 (es) 2022-02-25

Family

ID=56080208

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17711205T Active ES2896734T3 (es) 2016-03-18 2017-03-17 Proteínas novedosas derivadas de la alfa-1-microglobulina y su uso

Country Status (15)

Country Link
US (1) US10981963B2 (https=)
EP (1) EP3430032B1 (https=)
JP (1) JP6976579B2 (https=)
KR (1) KR102437662B1 (https=)
CN (1) CN108779157B (https=)
AU (1) AU2017235608B2 (https=)
BR (1) BR112018068522A2 (https=)
CA (1) CA3017836A1 (https=)
EA (1) EA039776B1 (https=)
ES (1) ES2896734T3 (https=)
MX (1) MX2018011193A (https=)
NZ (1) NZ746677A (https=)
SG (1) SG11201807352XA (https=)
WO (1) WO2017158181A1 (https=)
ZA (1) ZA201805797B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200345810A1 (en) * 2017-11-03 2020-11-05 Guard Therapeutics International AB Use of alpha-1-microglobulin for protection of bone marrow cells
KR20250142345A (ko) 2023-02-08 2025-09-30 가드 테라퓨틱스 인터내셔널 에이비 알파-1-마이크로글로불린 유래 펩타이드 단편 및 이의 용도
US12227343B2 (en) * 2023-03-17 2025-02-18 Blue Buffalo Enterpises, Inc. Retail ready opening feature for e-commerce carton

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20160760T1 (hr) * 2008-07-18 2016-08-12 A1M Pharma Ab Medicinska uporaba čistača radikala i antioksidacijskog alfa-1-mikroglobulina
US9758554B2 (en) * 2012-01-31 2017-09-12 Technische Universitaet Muenchen Muteins of α1m lipocalin and method of production therefor
JP2015533790A (ja) * 2012-09-05 2015-11-26 エー1エム ファーマ エービーA1M Pharma AB ミトコンドリア関連疾患の治療に使用するためのα−1−ミクログロブリン
US8727893B2 (en) * 2012-09-21 2014-05-20 Beintoo, S.P.A. Interactive experience fully contained within an expandable embedded unit
US10226570B2 (en) * 2017-03-10 2019-03-12 Seton Healthcare Family Apparatus and method for temporarily securing a movable accessory device relative to a movable patient

Also Published As

Publication number Publication date
EP3430032A1 (en) 2019-01-23
AU2017235608B2 (en) 2020-10-22
KR20180127411A (ko) 2018-11-28
MX2018011193A (es) 2019-03-28
US20190161524A1 (en) 2019-05-30
EA039776B1 (ru) 2022-03-11
EA201892085A1 (ru) 2019-02-28
ZA201805797B (en) 2022-03-30
EP3430032B1 (en) 2021-09-01
WO2017158181A1 (en) 2017-09-21
CN108779157A (zh) 2018-11-09
SG11201807352XA (en) 2018-09-27
JP6976579B2 (ja) 2021-12-08
NZ746677A (en) 2023-02-24
KR102437662B1 (ko) 2022-08-29
BR112018068522A2 (pt) 2019-01-22
US10981963B2 (en) 2021-04-20
AU2017235608A1 (en) 2018-10-18
JP2019519466A (ja) 2019-07-11
CA3017836A1 (en) 2017-09-21
CN108779157B (zh) 2022-12-30

Similar Documents

Publication Publication Date Title
CA2862516C (en) Compositions and methods of use for treating metabolic disorders
ES2614490T3 (es) Uso médico de la alfa 1-microglobulina antioxidante y eliminadora de radicales
US20220370560A1 (en) Ptd-smad7 therapeutics
KR20090033878A (ko) 허혈성 질환의 완화 및 치료를 위한 약학 조성물 및 그를 전달하기 위한 방법
ES2599034T3 (es) Alfa-1-microglobulina para su uso en el tratamiento de enfermedades relacionadas con mitocondrias
ES2896734T3 (es) Proteínas novedosas derivadas de la alfa-1-microglobulina y su uso
CA2906775A1 (en) Bh4 stabilized peptides and uses thereof
CN100537602C (zh) Ec sod和细胞转导性ec sod及它们的用途
KR102221041B1 (ko) 신증후군 및 관련 병태의 치료 방법
US10960048B2 (en) Alpha-1-microglobulin for use in the protection of kidneys in radionuclide therapy
ES2353674T3 (es) Factores de unión del factor ii de crecimiento similar a la insulina (igf-ii).
ES2819238T3 (es) Agente farmacéutico polipeptídico de proteína X contra el virus de la hepatitis B
JP2026507475A (ja) α-1-ミクログロブリン由来ペプチド断片及びその使用
US20190054142A1 (en) Alpha-1-microglobulin for use in the protection of kidneys in connection with use of contrast media
CN113474003A (zh) 谷氨酰胺合成酶用于治疗脂肪性肝病的用途